Navigation Links
Study in the New England Journal of Medicine Shows Non-Surgical Treatment for Pre-Cancerous Condition of Esophagus is Effective and Reduces Risk for Cancer Development
Date:5/27/2009

Data show superiority of endoscopic ablation therapy using the HALO System for eradicating Barrett's esophagus in randomized, multicenter, sham controlled trial

SUNNYVALE, Calif., May 27 /PRNewswire/ -- Results from a clinical study published today in the New England Journal of Medicine reveal that ablative therapy using the HALO system (BARRX Medical, Inc.) is highly effective for complete eradication of a pre-cancerous condition of the esophagus called Barrett's esophagus afflicting more than 3.3 million Americans. Additionally, ablative therapy using the HALO system reduced the risk of progression to cancer in the highest risk cohort studied (compared to control) from 19.0% to 2.4%.

The study entitled "Radiofrequency Ablation in Barrett's Esophagus with Dysplasia" is authored by lead investigator Nicholas J. Shaheen, M.D., Associate Professor of Medicine and Epidemiology, The University of North Carolina in Chapel Hill.

"This is a well-designed trial conducted in a rigorous manner at 19 expert U.S. centers, each having experience in the management of Barrett's esophagus, dysplasia, and cancer," said Dr. Shaheen. "Our results reported in the Journal are very promising, demonstrating superiority of ablation therapy for eliminating Barrett's and dysplasia, as well as reducing the rate of disease progression to more severe forms of dysplasia and esophageal cancer. This and data from other recent trials may ultimately change the paradigm for how gastroenterologists manage their patients with this disease."

As a result of chronic injury from gastroesophageal reflux disease (GERD), the normal esophageal lining is replaced with abnormal cells (Barrett's tissue), predisposing the patient to a higher risk for developing cancer of the esophagus. Patients with Barrett's who develop cancer, typically do so through a series of steps, starting with early Barrett's, then low
'/>"/>

SOURCE BARRX Medical, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Theranostics Health Announces Involvement with Major Academic Medical Center in Study Funded by Susan G. Komen for the Cure(R)
2. New Phase 3 Study of Tapentadol Immediate Release Tablets Published in Current Medical Research and Opinion Journal
3. New Study Evaluating the ADHD Medication VYVANSE(R) (lisdexamfetamine dimesylate) CII Demonstrated No Change in the Pharmacokinetic Profile of VYVANSE When Coadministered with Prilosec OTC(R) 40 mg (20 mg X 2), a Commonly Used Proton Pump Inhibitor (PPI)
4. Long Term Data Presented at EuroPCR 2009 from Randomized Study Attest to Durability of Results of OrbusNeichs Genous(TM) Bio-engineered R stent(TM) Compared to Drug-Eluting Stents
5. New NIH-Funded Study Shows Masimo Rainbow SET(R) May Help Clinicians Assess Oxygenation in Children With Sickle Cell Disease
6. Study Confirms Effectiveness of Innovative Prism Glasses For Hemianopia Patients
7. Shire Announces Study Results of the Effects of INTUNIV(TM) (Guanfacine) Extended Release on Secondary Measures in Children with ADHD and Oppositional Symptoms
8. Optimer Pharmaceuticals Presents Results From Fidaxomicin Phase 3 Study for the Treatment of Clostridium difficile Infection
9. VIVUS Initiates Open Label Safety Study of Avanafil for Erectile Dysfunction
10. VIDEO from Medialink and the Epilepsy Foundation: New Study Suggests Different Versions of the Same Epilepsy Medication Can Be Harmful
11. Ongoing Landmark ROADMAP Study Demonstrates Significant Improvement in Blood Pressure Control at One Year, According to Blinded Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2015)... VANCOUVER, British Columbia and MENLO ... DelMar Pharmaceuticals, Inc. (OTCQX: DMPI) ("DelMar" and the ... commercialization of new cancer therapies, today announced its financial ... and provided an overview of recent Company highlights and ... will host a business update conference call and live ...
(Date:9/3/2015)... , Sept. 3, 2015  Cipla, a global pharmaceutical ... everyday needs of all patients, today announced that its ... to acquire two US-based companies, InvaGen Pharmaceuticals Inc., and ... closing conditions, is valued at $550 million and will ... these transactions is over $200 million for the year ...
(Date:9/3/2015)... Sept. 3, 2015 Report Details ... Which areas are going to grow at the fastest ... to 2025, assessing data, trends, opportunities and prospects there. ... and graphs. Discover the most lucrative areas in the ... lets you assess forecasted sales at overall world market ...
Breaking Medicine Technology:DelMar Pharmaceuticals Reports Fiscal 2015 Year-End Financial Results and Provides Corporate Update 2DelMar Pharmaceuticals Reports Fiscal 2015 Year-End Financial Results and Provides Corporate Update 3DelMar Pharmaceuticals Reports Fiscal 2015 Year-End Financial Results and Provides Corporate Update 4DelMar Pharmaceuticals Reports Fiscal 2015 Year-End Financial Results and Provides Corporate Update 5DelMar Pharmaceuticals Reports Fiscal 2015 Year-End Financial Results and Provides Corporate Update 6DelMar Pharmaceuticals Reports Fiscal 2015 Year-End Financial Results and Provides Corporate Update 7DelMar Pharmaceuticals Reports Fiscal 2015 Year-End Financial Results and Provides Corporate Update 8Cipla to acquire 100% of generic businesses in US for $550M 2Cipla to acquire 100% of generic businesses in US for $550M 3Cipla to acquire 100% of generic businesses in US for $550M 4Cipla to acquire 100% of generic businesses in US for $550M 5Ophthalmic Devices Market Forecast 2015-2025: Future Prospects for Leading Companies in Vision Care, Surgical, Diagnostic & Monitoring Devices 2Ophthalmic Devices Market Forecast 2015-2025: Future Prospects for Leading Companies in Vision Care, Surgical, Diagnostic & Monitoring Devices 3Ophthalmic Devices Market Forecast 2015-2025: Future Prospects for Leading Companies in Vision Care, Surgical, Diagnostic & Monitoring Devices 4
... June 27, 2011 Pepto-Bismol announced today that for the ... red, white and … PINK? In an act of true ... the Nathan,s Famous Fourth of July International Hot Dog Eating ... To make this contest a celebration to remember, Pepto-Bismol ...
... China, June 27, 2011 /PRNewswire-Asia/ -- Shenzhen Wuzhou Changlian ... health care electronics & medical equipment, announces its new ... have become the indispensable parts for people to easily ... To cater to those patients or people ...
Cached Medicine Technology:Pepto-Bismol and Nick Cannon Heat Things up at this Year's Nathan's Famous Fourth of July International Hot Dog Eating Contest 2Pepto-Bismol and Nick Cannon Heat Things up at this Year's Nathan's Famous Fourth of July International Hot Dog Eating Contest 3New Arrivals of Exercise & Health Care Equipment 2
(Date:9/4/2015)... ... September 04, 2015 , ... According to an article published September ... in nursing homes and assisted living facilities are receiving insufficient care that could actually ... her father was at one point close to death, not because of a medical ...
(Date:9/4/2015)... , ... September 04, 2015 , ... With TransCel from ... mouse all within Final Cut Pro X. With TransCel users have full control over ... width, background color, speed method, frame color, inner color, text, and more. With TransCel ...
(Date:9/4/2015)... ... ... New England, one of the largest and most successful fertility centers in the nation, ... wish to learn more about their fertility and egg freezing. , Date and Time: ... NH from 6PM to 7PM , This hip, casual and informative event will discuss ...
(Date:9/4/2015)... NC (PRWEB) , ... September 04, 2015 , ... ... Night out to benefit Core Compassion Project. Core Compassion Project is a ... specialized program to reduce the side effects of cancer treatments and recover their ...
(Date:9/4/2015)... ... September 04, 2015 , ... “Getting away from the daily stressors and distractions ... and strengthen their ‘couple-ness,’” says Jean Claude Wietzel, general manager at Four Seasons ... the island’s only Forbes Five Star resort and Travel + Leisure’s No. 1 Hotel ...
Breaking Medicine News(10 mins):Health News:Op-Ed about Insufficient Care for Elderly Patients Highlights the Advantages of Quality, At-Home Care, says Dr. Michael Farzam 2Health News:Op-Ed about Insufficient Care for Elderly Patients Highlights the Advantages of Quality, At-Home Care, says Dr. Michael Farzam 3Health News:Pixel Film Studios Releases TransCel, a New FCPX Transition 2Health News:IVF New England to Host ManchVegas New Hampshire Fertility Happy Hour on October 15, 2015 in Manchester for Women Who Wish to Learn More About Fertility and Egg Freezing 2Health News:Girl’s Night Out to Benefit Core Compassion Project, Located at the Beautiful, Morning Glory Farm 2Health News:Couples Season at Four Seasons Resort Maui Begins This Week With Best Hotel Rates of the Year through November 2Health News:Couples Season at Four Seasons Resort Maui Begins This Week With Best Hotel Rates of the Year through November 3
... for more careful screening for these patients, researcher says ... with metabolic syndrome have a 75 percent higher risk ... new study suggests. , "Metabolic syndrome is a conglomeration ... a worse prognosis for certain illnesses, including a number ...
... a protein that plays matchmaker between two key types ... them to interact in a way that is crucial ... finding may also explain why some individuals who have ... proteincalled SAPsuffer from lethal infections with a common virus ...
... The Johns Hopkins University School,of Medicine is ... Cancer Strategies: From Biomarkers to Treatment,Selection," to present ... in,breast cancer treatment., In recent years, advancements ... chemotherapeutic and biologic treatment combinations that are,increasingly tailored ...
... Molecular CT adds metabolic information from PET to traditional ... for maximized workflow ... and quick return on investment, MUNICH, Germany, Oct. ... a new concept in,integrated imaging that provides a premium ...
... This may sound like,science fiction, but it is truly ... become the first U.S. doctor,licensed to provide TA-65 to ... Beach, Florida., This is a revolutionary technology that ... DNA. They are located at the ends of all ...
... Oct. 9 After a thorough review of ... (VDSS),announced that it has selected Policy Studies Inc. ... the Chesapeake and Hampton districts.,PSI is a leading ... The contract is valued at approximately $7 million ...
Cached Medicine News:Health News:Metabolic Syndrome Raises Colon Cancer Risk 75% 2Health News:Metabolic Syndrome Raises Colon Cancer Risk 75% 3Health News:NIH scientists discover crucial control in long-lasting immunity 2Health News:NIH scientists discover crucial control in long-lasting immunity 3Health News:Latest Research on Breast Cancer Presented in a Virtual E-Conference CME Course 2Health News:Siemens Shapes the Future of Integrated Diagnostic Imaging 2Health News:Siemens Shapes the Future of Integrated Diagnostic Imaging 3Health News:Siemens Shapes the Future of Integrated Diagnostic Imaging 4Health News:Science Fiction Has Become Reality with Remarkable Anti-Aging Treatment Breakthrough - Turning Back the Biological Clock in Aging 2Health News:Science Fiction Has Become Reality with Remarkable Anti-Aging Treatment Breakthrough - Turning Back the Biological Clock in Aging 3Health News:PSI Selected to Operate Virginia's Child Support Program in Chesapeake and Hampton 2
... Medical IQ 810 infrared diode laser ... disorders and glaucoma. The Companys top-of-the-line, ... innovation and is designed to perform ... procedures in the office and operating ...
... in the evolution of lens design for the ... become the world's most frequently prescribed rigid gas ... the complex geometry built into every Rose K ... of the cornea, for every stage of the ...
... is winning the hearts of cardiologists and ... are the operative words for Heartline™. Patients ... time they and their attending physician know ... in their heart condition is only a ...
... Eyelid Implants feature a proprietary three-dimensional design ... ocular globe. The Contour Eyelid Implant ... eyelid because the tapered lower edge and ... Surfaces and edges of the implant are ...
Medicine Products: